Trials / Conditions / NSCLC Stage IIIB~IV
NSCLC Stage IIIB~IV
3 registered clinical trials studyying NSCLC Stage IIIB~IV — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Immune-Marker Platform for Patients With Advanced Lung Cancer NCT07150598 | Technische Universität Dresden | — |
| Completed | A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination w NCT04909034 | Microbio Co Ltd | N/A |
| Active Not Recruiting | A Phase II Study of Atezolizumab in Combination With Bevacizumab, Carboplatin or Cisplatin, and Pemetrexed for NCT04147351 | National Taiwan University Hospital | Phase 2 |